AM712

· AffaMed Therapeutics Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AM712, covering 2024-12-12 to 2024-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AM712 in Patients with NAMD [Phase 1]